A two year campaign to overturn the NHS withholding of Alzheimer’s drugs from people with early stages of the disease has ended in bitter disappointment for lobby groups after the High Court chose to support the government’s drugs watchdog.The first-ever judicial review into a recommendation from the National Institute for Health and Clinical Excellence (NICE)…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
